ACT Capital Advisors is pleased to offer Medical Technology Assets (including patents and other intellectual property) for acquisition. The physical assets and IP relate to proprietary hemostatic dressings and materials and represent one of the first meaningful solutions for life-threatening hemorrhagic events.
For more information, please fill out the form at the bottom of this page. If you are interested in pursuing this acquisition further, kindly execute the Confidentiality Agreement linked below, and return it to Dan Nicklaus at firstname.lastname@example.org. If you have questions, you can reach Dan at (206) 920-5832.